205382-87-2

Basic information

• Product Name: 5-Oxazolidinecarboxylicacid,2-oxo-,methylester,(5S)-(9CI)
• Synonyms: 5-Oxazolidinecarboxylicacid,2-oxo-,methylester,(5S)-(9CI)
• CAS NO: 205382-87-2
• Molecular Formula: C5H7NO4
• Molecular Weight: 145.11
• Product Categories: CARBOXYLICESTER
• Mol File: 205382-87-2.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-Oxazolidinecarboxylicacid,2-oxo-,methylester,(5S)-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Oxazolidinecarboxylicacid,2-oxo-,methylester,(5S)-(9CI)(205382-87-2)
• EPA Substance Registry System: 5-Oxazolidinecarboxylicacid,2-oxo-,methylester,(5S)-(9CI)(205382-87-2)

Safety Data

• Hazardous Substances Data: 205382-87-2(Hazardous Substances Data)

Upstream product

• 66212-45-1 (2S)-2-hydroxy-butanedioic acid 1-mono methyl ester 
• 83540-94-7 (R)-2-hydroxybutanedioic acid 1-methylester 
• 67-56-1 methanol 
• 71764-58-4 C₇H₁₁Cl₂NO₄ 
• 13698-14-1 β--α-chlor-propionsaeure-methylester 

Relevant articles and documents

Application of the DP4 Probability Method to Flexible Cyclic Peptides with Multiple Independent Stereocenters: The True Structure of Cyclocinamide A

A DP4 protocol has been successfully utilized to establish the true structure of the natural product cyclocinamide A, a flexible cyclic peptide with four isolated stereocenters. Benchmarking the necessary level of theory required to successfully predict t

POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC M2 RECEPTOR

The present application relates to positive allosteric modulators of the muscarinic M2 receptor, especially to novel 7-substituted 1-arylnaphthyridine-3-carboxamides, to processes for preparation thereof, to the use thereof, alone or in combinations, for treatment and/or prevention of diseases, and to the use thereof for production of medicaments for treatment and/or prevention of diseases, in particular for treatment and/or prevention of cardiovascular disorders and/or renal disorders.

Synthesis of homochiral tetrahydropteridines

A synthesis of protected homochiral tetrahydropteridines from (2S)-malic acid has been developed. This presents methodology for the synthesis of reduced pteridine coenzymes and pharmaceuticals.

Efficient synthesis of N-benzyloxycarbonyl- and N-tert-butoxycarbonyl-(S)-isoserine and their derivatives

A mild and efficient synthesis of N-protected (S)-isoserine from (S)-malic acid monoester via an oxazolidin-2-one is described.

Influence of lewis acids on the regioselectivity of N-Boc-aziridine-2-carboxylate microwave-assisted rearrangement

The microwave assisted rearrangement of N-Boc-chiral aziridine-2-imides and esters to oxazolidin-2-ones in the presence of different Lewis acids is presented. The regioselectivity of the reaction strongly depends upon the Lewis acid selected and the react

REACTIVITY OF N,N-DICHLOROURETHANES. IX. ADDITION OF N,N-DICHLOROURETHANES TO ALKENES WITH ELECTRON-WITHDRAWING GROUPS

The addition of N,N-dichlorourethanes to derivatives of acrylic acid in the presence of catalytic amounts of copper powder or cuprous chloride gave the adducts RCHClCH2N(Cl)COOAlk, where R = CN, COOCH3, and CONH2.When treated with an aqueous solution of s